DTIL (STOCKS)
Precision BioSciences, Inc. Common Stock
$7.130000
+0.460000 (+6.90%)
Prev close: $6.670000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Michael Amoroso
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $176.30M
- Employees
- 67
- P/E (TTM)
- -1.38
- P/B (TTM)
- 1.86
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.05 | $-0.55 | +1.5957 | +292.41% |
|
Sep 2025 (Q3)
|
$-1.84 | $-1.37 | -0.4732 | -34.62% |
|
Jun 2025 (Q2)
|
$-2.13 | $-1.60 | -0.5320 | -33.29% |
|
Mar 2025 (Q1)
|
$-2.21 | $-1.75 | -0.4590 | -26.21% |
Financial Statements
| Revenues | $34.26M |
| Benefits Costs and Expenses | $79.99M |
| Costs And Expenses | $79.99M |
| Operating Expenses | $86.41M |
| Depreciation and Amortization | $1.47M |
| Research and Development | $54.17M |
| Other Operating Expenses | $30.77M |
| Operating Income/Loss | -$52.15M |
| Income/Loss Before Equity Method Investments | -$45.72M |
| Income/Loss From Continuing Operations After Tax | -$46.61M |
| Income/Loss From Continuing Operations Before Tax | -$45.72M |
| Income/Loss From Discontinued Operations Net Of Tax | $885.00K |
| Income/Loss From Equity Method Investments | -$5.28M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$45.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$45.72M |
| Net Income/Loss Available To Common Stockholders, Basic | -$45.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$3.56 |
| Diluted Earnings Per Share | -$3.56 |
| Basic Average Shares | 12,826,078 |
| Diluted Average Shares | 12,826,078 |
| Assets | $154.42M |
| Current Assets | $118.74M |
| Prepaid Expenses | $3.11M |
| Other Current Assets | $115.63M |
| Noncurrent Assets | $35.68M |
| Fixed Assets | $1.43M |
| Intangible Assets | $1.17M |
| Other Non-current Assets | $33.09M |
| Liabilities | $62.17M |
| Current Liabilities | $8.91M |
| Accounts Payable | $296.00K |
| Wages | $4.75M |
| Other Current Liabilities | $3.87M |
| Noncurrent Liabilities | $53.26M |
| Equity | $92.25M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $92.25M |
| Liabilities And Equity | $154.42M |
| Net Cash Flow From Operating Activities | -$65.84M |
| Net Cash Flow From Operating Activities, Continuing | -$65.84M |
| Net Cash Flow From Investing Activities | -$634.00K |
| Net Cash Flow From Investing Activities, Continuing | -$634.00K |
| Net Cash Flow From Financing Activities | $95.16M |
| Net Cash Flow From Financing Activities, Continuing | $95.16M |
| Net Cash Flow | $28.69M |
| Net Cash Flow, Continuing | $28.69M |
| Comprehensive Income/Loss | -$45.72M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$45.72M |
| Other Comprehensive Income/Loss | $0.00 |